Damon Joe  membuat artikel baru
4 tahun

The blood-brain barrier (BB penetrating drugs market is estimated to be worth USD 900 million in 2030, predicts Roots Analysis | #central nervous system # blood brain barrier # cns drugs # blood csf barrier

The blood-brain barrier (BBB) penetrating drugs market is estimated to be worth USD 900 million in 2030, predicts Roots

The blood-brain barrier (BBB) penetrating drugs market is estimated to be worth USD 900 million in 2030, predicts Roots

An overview of the overall landscape of BBB penetration technologies, featuring an in-depth analysis of the technologies based on a number of parameters